News & Events about Haemonetics Corp.
Latest Ratings for HAE
DateFirmActionFromTo Feb 2022Raymond JamesMaintainsOutperform Jan 2022NeedhamDowngradesBuyHold Jan 2022Morgan StanleyMaintainsEqual-Weight
View More Analyst Ratings for HAE
View the Latest Analyst Ratings
read more...
Haemonetics (NYSE:HAE Get Rating) had its price objective raised by Citigroup from $88.00 to $92.00 in a report released on Monday morning, The Fly reports. Citigroup currently has a neutral rating on the medical instruments suppliers stock. HAE has been the topic of a number of other reports. ...
TheStreet upgraded shares of Haemonetics (NYSE:HAE Get Rating) from a c+ rating to a b rating in a research note released on Monday morning, TheStreetRatingsTable reports. Other research analysts have also issued research reports about the stock. Citigroup increased their target price on shares of ...
Haemonetics (NYSE:HAE Get Rating) and Ra Medical Systems (NYSE:RMED Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and ...